Delivery Order SPE2DB22D2005-SPE2DB24FJJJ0
- Not listed
- This federal contract award, valued at $30,713.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The contract has a completion date of February 7, 2024 and is a firm fixed-price delivery order. No set-aside designation was applied. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $2,537.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and other conditions. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.52 firm-fixed-price delivery order is for the supply of 4,565,753,142 tablets of Bupropion HCl XL 150 mg, a generic medication used to treat depression and smoking cessation. The contract has a completion date of September 11, 2024 and was awarded on September 10, 2024. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,407.58 firm fixed-price delivery order is for the provision of 4,563,605,046 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp is an established pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA). The $39,018.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 29, 2024. The contract has an ultimate completion date of April 1, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $13,869.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets in quantities of 500 tablets per bottle. This is a Firm Fixed Price Delivery Order contract with a completion date of February 8, 2024. The contract was awarded on February 7, 2024 and does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
- This federal contract award, valued at $35,290.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a medication used to treat depression and to help people quit smoking. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $38,618.22 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCl XL 300 mg tablets, which are used to treat mental health conditions. The award has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJJJ0Delivery Order
This federal contract award, valued at $14,671.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a medication used to treat depression and other conditions. The contract is a firm-fixed-price delivery order with a period of performance through March 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, as well as the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a comprehensive range of pharmaceutical products and medical supplies. These IDCs serve as primary vehicles for the efficient procurement of essential healthcare commodities to support military, veteran, and other federal beneficiary needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 2/29/24 |